{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:55:16Z","timestamp":1784357716887,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,2,22]],"date-time":"2018-02-22T00:00:00Z","timestamp":1519257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1038\/s41375-018-0066-4","type":"journal-article","created":{"date-parts":[[2018,2,22]],"date-time":"2018-02-22T16:04:59Z","timestamp":1519315499000},"page":"2211-2223","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Novel phosphorylated TAK1 species with functional impact on NF-\u03baB and \u03b2-catenin signaling in human Cutaneous T-cell lymphoma"],"prefix":"10.1038","volume":"32","author":[{"given":"Fernando","family":"Gallardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Bertran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"L\u00f3pez-Arribillaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9ssica","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Men\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Colomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Francisco","family":"Santamar\u00eda-Bab\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7355-7913","authenticated-orcid":false,"given":"Ferran","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon M","family":"Pujol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bigas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llu\u00eds","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,22]]},"reference":[{"key":"66_CR1","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.critrevonc.2015.12.018","volume":"99","author":"PL Zinzani","year":"2016","unstructured":"Zinzani PL, Bonthapally V, Huebner D, Lutes R, Chi A, Pileri S. Panoptic clinical review of the current and future treatment of relapsed\/refractory T-cell lymphomas: cutaneous T-cell lymphomas. Crit Rev Oncol\/Hematol. 2016;99:228\u2013240.","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"13","key":"66_CR2","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.1158\/1078-0432.CCR-15-1784","volume":"22","author":"PA Vieyra-Garcia","year":"2016","unstructured":"Vieyra-Garcia PA, Wei T, Naym DG, Fredholm S, Fink-Puches R, Cerroni L, et al. STAT3\/5-Dependent IL9 Overexpression contributes to neoplastic cell survival in mycosis fungoides. Clin Cancer Res 2016;22(13):3328\u201339.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"66_CR3","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1038\/jid.2012.203","volume":"132","author":"L Fits van der","year":"2012","unstructured":"van der Fits L, Qin Y, Out-Luiting JJ, Vermeer KG, Whittaker S, van Es JH, et al. NOTCH1 signaling as a therapeutic target in Sezary syndrome. J Invest Dermatol. 2012;132(12):2810\u20137.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"66_CR4","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/leu.2011.198","volume":"26","author":"RC McKenzie","year":"2012","unstructured":"McKenzie RC, Jones CL, Tosi I, Caesar JA, Whittaker SJ, Mitchell TJ. Constitutive activation of STAT3 in Sezary syndrome is independent of SHP-1. Leukemia. 2012;26(2):323\u201331.","journal-title":"Leukemia"},{"issue":"14","key":"66_CR5","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1182\/blood-2009-12-260216","volume":"116","author":"MR Kamstrup","year":"2010","unstructured":"Kamstrup MR, Gjerdrum LM, Biskup E, Lauenborg BT, Ralfkiaer E, Woetmann A, et al. Notch1 as a potential therapeutic target in cutaneous T-cell lymphoma. Blood. 2010;116(14):2504\u201312.","journal-title":"Blood"},{"issue":"12","key":"66_CR6","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1038\/jid.2015.328","volume":"135","author":"F Gallardo","year":"2015","unstructured":"Gallardo F, Sandoval J, Diaz-Lagares A, Garcia R, D\u2019Altri T, Gonzalez J, et al. Notch1 pathway activation results from the epigenetic abrogation of notch-related MicroRNAs in Mycosis Fungoides. J Invest Dermatol. 2015;135(12):3144\u201352.","journal-title":"J Invest Dermatol"},{"issue":"6","key":"66_CR7","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1111\/j.1365-2133.2006.07527.x","volume":"155","author":"B Bellei","year":"2006","unstructured":"Bellei B, Cota C, Amantea A, Muscardin L, Picardo M. Association of p53 Arg72Pro polymorphism and beta-catenin accumulation in mycosis fungoides. Br J Dermatol. 2006;155(6):1223\u20139.","journal-title":"Br J Dermatol"},{"issue":"12","key":"66_CR8","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1038\/ng.3442","volume":"47","author":"AC Silva Almeida da","year":"2015","unstructured":"da Silva Almeida AC, Abate F, Khiabanian H, Martinez-Escala E, Guitart J, Tensen CP, et al. The mutational landscape of cutaneous T cell lymphoma and Sezary syndrome. Nat Genet. 2015;47(12):1465\u201370.","journal-title":"Nat Genet"},{"issue":"9","key":"66_CR9","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/ng.3370","volume":"47","author":"A Ungewickell","year":"2015","unstructured":"Ungewickell A, Bhaduri A, Rios E, Reuter J, Lee CS, Mah A, et al. Genomic analysis of mycosis fungoides and Sezary syndrome identifies recurrent alterations in TNFR2. Nat Genet. 2015;47(9):1056\u201360.","journal-title":"Nat Genet"},{"issue":"9","key":"66_CR10","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/ng.3356","volume":"47","author":"J Choi","year":"2015","unstructured":"Choi J, Goh G, Walradt T, Hong BS, Bunick CG, Chen K, et al. Genomic landscape of cutaneous T cell lymphoma. Nat Genet. 2015;47(9):1011\u20139.","journal-title":"Nat Genet"},{"issue":"9","key":"66_CR11","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/leu.2011.101","volume":"25","author":"FC Braun","year":"2011","unstructured":"Braun FC, Grabarczyk P, Mobs M, Braun FK, Eberle J, Beyer M, et al. Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sezary syndrome. Leukemia. 2011;25(9):1494\u2013501.","journal-title":"Leukemia"},{"issue":"12","key":"66_CR12","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1084\/jem.194.12.1861","volume":"194","author":"RE Davis","year":"2001","unstructured":"Davis RE, Brown KD, Siebenlist U, Staudt LM. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med. 2001;194(12):1861\u201374.","journal-title":"J Exp Med"},{"issue":"7277","key":"66_CR13","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nature08638","volume":"463","author":"RE Davis","year":"2010","unstructured":"Davis RE, Ngo VN, Lenz G, Tolar P, Young RM, Romesser PB, et al. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature. 2010;463(7277):88\u201392.","journal-title":"Nature"},{"issue":"1","key":"66_CR14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4049\/jimmunol.163.1.269","volume":"163","author":"S Doerre","year":"1999","unstructured":"Doerre S, Corley RB. Constitutive nuclear translocation of NF-kappa B in B cells in the absence of I kappa B degradation. J Immunol. 1999;163(1):269\u201377.","journal-title":"J Immunol"},{"issue":"29","key":"66_CR15","doi-asserted-by":"publisher","first-page":"4224","DOI":"10.1038\/onc.2017.90","volume":"36","author":"X Guo","year":"2017","unstructured":"Guo X, Koff JL, Moffitt AB, Cinar M, Ramachandiran S, Chen Z, et al. Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype. Oncogene. 2017;36(29):4224\u201332.","journal-title":"Oncogene"},{"issue":"1","key":"66_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S1074-7613(01)00258-8","volume":"16","author":"LV Pham","year":"2002","unstructured":"Pham LV, Tamayo AT, Yoshimura LC, Lo P, Terry N, Reid PS, et al. A CD40 Signalosome anchored in lipid rafts leads to constitutive activation of NF-kappaB and autonomous cell growth in B cell lymphomas. Immunity. 2002;16(1):37\u201350.","journal-title":"Immunity"},{"issue":"6","key":"66_CR17","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/nrgastro.2010.58","volume":"7","author":"X Sagaert","year":"2010","unstructured":"Sagaert X, Van Cutsem E, De Hertogh G, Geboes K, Tousseyn T. Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development. Nat Rev Gastroenterol Hepatol. 2010;7(6):336\u201346.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"66_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0092-8674(00)80957-5","volume":"96","author":"TG Willis","year":"1999","unstructured":"Willis TG, Jadayel DM, Du MQ, Peng H, Perry AR, Abdul-Rauf M, et al. Bcl10 is involved in t(1;14)(p22; q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell. 1999;96(1):35\u201345.","journal-title":"Cell"},{"issue":"6","key":"66_CR19","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.4049\/jimmunol.1402610","volume":"194","author":"TP Chang","year":"2015","unstructured":"Chang TP, Poltoratsky V, Vancurova I. Bortezomib inhibits expression of TGF-beta1, IL-10, and CXCR4, resulting in decreased survival and migration of cutaneous T cell lymphoma cells. J Immunol. 2015;194(6):2942\u201353.","journal-title":"J Immunol"},{"issue":"5","key":"66_CR20","first-page":"433","volume":"3","author":"TP Chang","year":"2013","unstructured":"Chang TP, Vancurova I. NFkappaB function and regulation in cutaneous T-cell lymphoma. Am J Cancer Res. 2013;3(5):433\u201345.","journal-title":"Am J Cancer Res"},{"issue":"4","key":"66_CR21","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1084\/jem.20091346","volume":"208","author":"L Li","year":"2011","unstructured":"Li L, Ruan Q, Hilliard B, Devirgiliis J, Karin M, Chen YH. Transcriptional regulation of the Th17 immune response by IKK(alpha). J Exp Med. 2011;208(4):787\u201396.","journal-title":"J Exp Med"},{"issue":"5","key":"66_CR22","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ni.2267","volume":"13","author":"JH Chang","year":"2012","unstructured":"Chang JH, Xiao Y, Hu H, Jin J, Yu J, Zhou X, et al. Ubc13 maintains the suppressive function of regulatory T cells and prevents their conversion into effector-like T cells. Nat Immunol. 2012;13(5):481\u201390.","journal-title":"Nat Immunol"},{"issue":"8","key":"66_CR23","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.4049\/jimmunol.168.8.3721","volume":"168","author":"H Ren","year":"2002","unstructured":"Ren H, Schmalstieg A, van Oers NS, Gaynor RB. I-kappa B kinases alpha and beta have distinct roles in regulating murine T cell function. J Immunol. 2002;168(8):3721\u201331.","journal-title":"J Immunol"},{"issue":"5","key":"66_CR24","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S1074-7613(00)00067-4","volume":"13","author":"RE Voll","year":"2000","unstructured":"Voll RE, Jimi E, Phillips RJ, Barber DF, Rincon M, Hayday AC, et al. NF-kappa B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development. Immunity. 2000;13(5):677\u201389.","journal-title":"Immunity"},{"issue":"3","key":"66_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S1074-7613(01)00104-2","volume":"14","author":"U Senftleben","year":"2001","unstructured":"Senftleben U, Li ZW, Baud V, Karin M. IKKbeta is essential for protecting T cells from TNFalpha-induced apoptosis. Immunity. 2001;14(3):217\u201330.","journal-title":"Immunity"},{"issue":"3","key":"66_CR26","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S1074-7613(03)00237-1","volume":"19","author":"M Schmidt-Supprian","year":"2003","unstructured":"Schmidt-Supprian M, Courtois G, Tian J, Coyle AJ, Israel A, Rajewsky K, et al. Mature T cells depend on signaling through the IKK complex. Immunity. 2003;19(3):377\u201389.","journal-title":"Immunity"},{"issue":"3","key":"66_CR27","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ccr.2010.08.006","volume":"18","author":"L Espinosa","year":"2010","unstructured":"Espinosa L, Cathelin S, D\u2019Altri T, Trimarchi T, Statnikov A, Guiu J, et al. The Notch\/Hes1 pathway sustains NF-kappaB activation through CYLD repression in T cell leukemia. Cancer Cell. 2010;18(3):268\u201381.","journal-title":"Cancer Cell"},{"issue":"31","key":"66_CR28","doi-asserted-by":"publisher","first-page":"18347","DOI":"10.1074\/jbc.270.31.18347","volume":"270","author":"SC Sun","year":"1995","unstructured":"Sun SC, Maggirwar SB, Harhaj E. Activation of NF-kappa B by phosphatase inhibitors involves the phosphorylation of I kappa B alpha at phosphatase 2A-sensitive sites. J Biol Chem. 1995;270(31):18347\u201351.","journal-title":"J Biol Chem"},{"issue":"35","key":"66_CR29","doi-asserted-by":"crossref","first-page":"26805","DOI":"10.1016\/S0021-9258(19)74384-1","volume":"268","author":"SD Menon","year":"1993","unstructured":"Menon SD, Qin S, Guy GR, Tan YH. Differential induction of nuclear NF-kappa B by protein phosphatase inhibitors in primary and transformed human cells. Requirement for both oxidation and phosphorylation in nuclear translocation. J Biol Chem. 1993;268(35):26805\u201312.","journal-title":"J Biol Chem"},{"issue":"5","key":"66_CR30","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/ni.1600","volume":"9","author":"HY Li","year":"2008","unstructured":"Li HY, Liu H, Wang CH, Zhang JY, Man JH, Gao YF, et al. Deactivation of the kinase IKK by CUEDC2 through recruitment of the phosphatase PP1. Nat Immunol. 2008;9(5):533\u201341.","journal-title":"Nat Immunol"},{"issue":"4","key":"66_CR31","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.immuni.2012.07.014","volume":"37","author":"M Brechmann","year":"2012","unstructured":"Brechmann M, Mock T, Nickles D, Kiessling M, Weit N, Breuer R, et al. A PP4 holoenzyme balances physiological and oncogenic nuclear factor-kappa B signaling in T lymphocytes. Immunity. 2012;37(4):697\u2013708.","journal-title":"Immunity"},{"issue":"6","key":"66_CR32","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.4049\/jimmunol.1302537","volume":"192","author":"M Gu","year":"2014","unstructured":"Gu M, Ouyang C, Lin W, Zhang T, Cao X, Xia Z, et al. Phosphatase holoenzyme PP1\/GADD34 negatively regulates TLR response by inhibiting TAK1 serine 412 phosphorylation. J Immunol. 2014;192(6):2846\u201356.","journal-title":"J Immunol"},{"issue":"35","key":"66_CR33","doi-asserted-by":"publisher","first-page":"24226","DOI":"10.1074\/jbc.M114.559963","volume":"289","author":"C Ouyang","year":"2014","unstructured":"Ouyang C, Nie L, Gu M, Wu A, Han X, Wang X, et al. Transforming growth factor (TGF)-beta-activated kinase 1 (TAK1) activation requires phosphorylation of serine 412 by protein kinase A catalytic subunit alpha (PKACalpha) and X-linked protein kinase (PRKX). J Biol Chem. 2014;289(35):24226\u201337.","journal-title":"J Biol Chem"},{"issue":"373","key":"66_CR34","doi-asserted-by":"publisher","first-page":"ra38","DOI":"10.1126\/scisignal.2005886","volume":"8","author":"P Margalef","year":"2015","unstructured":"Margalef P, Colomer C, Villanueva A, Montagut C, Iglesias M, Bellosillo B, et al. BRAF-induced tumorigenesis is IKKalpha-dependent but NF-kappaB-independent. Sci Signal. 2015;8(373):ra38.","journal-title":"Sci Signal"},{"issue":"5","key":"66_CR35","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1182\/blood-2012-12-471904","volume":"122","author":"D Kaveri","year":"2013","unstructured":"Kaveri D, Kastner P, Dembele D, Nerlov C, Chan S, Kirstetter P. beta-Catenin activation synergizes with Pten loss and Myc overexpression in Notch-independent T-ALL. Blood. 2013;122(5):694\u2013704.","journal-title":"Blood"},{"issue":"25","key":"66_CR36","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.1182\/blood-2014-10-609370","volume":"125","author":"V Giambra","year":"2015","unstructured":"Giambra V, Jenkins CE, Lam SH, Hoofd C, Belmonte M, Wang X, et al. Leukemia stem cells in T-ALL require active Hif1alpha and Wnt signaling. Blood. 2015;125(25):3917\u201327.","journal-title":"Blood"},{"issue":"10","key":"66_CR37","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1038\/leu.2016.106","volume":"30","author":"C Gekas","year":"2016","unstructured":"Gekas C, D\u2019Altri T, Aligue R, Gonzalez J, Espinosa L, Bigas A. beta-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1. Leukemia. 2016;30(10):2002\u201310.","journal-title":"Leukemia"},{"issue":"10","key":"66_CR38","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/modpathol.3800181","volume":"17","author":"B Bellei","year":"2004","unstructured":"Bellei B, Pacchiarotti A, Perez M, Faraggiana T. Frequent beta-catenin overexpression without exon 3 mutation in cutaneous lymphomas. Mod Pathol. 2004;17(10):1275\u201381.","journal-title":"Mod Pathol"},{"issue":"4","key":"66_CR39","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.cell.2011.12.033","volume":"148","author":"A Singh","year":"2012","unstructured":"Singh A, Sweeney MF, Yu M, Burger A, Greninger P, Benes C, et al. TAK1 inhibition promotes apoptosis in KRAS-dependent colon cancers. Cell. 2012;148(4):639\u201350.","journal-title":"Cell"},{"issue":"1","key":"66_CR40","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jcp.20055","volume":"201","author":"AA Birukova","year":"2004","unstructured":"Birukova AA, Smurova K, Birukov KG, Usatyuk P, Liu F, Kaibuchi K, et al. Microtubule disassembly induces cytoskeletal remodeling and lung vascular barrier dysfunction: role of Rho-dependent mechanisms. J Cell Physiol. 2004;201(1):55\u201370.","journal-title":"J Cell Physiol"},{"issue":"5","key":"66_CR41","doi-asserted-by":"publisher","first-page":"H398","DOI":"10.1152\/ajpheart.00691.2014","volume":"308","author":"M Chen","year":"2015","unstructured":"Chen M, Ma L, Hall JE, Liu X, Ying Z. Dual regulation of tumor necrosis factor-alpha on myosin light chain phosphorylation in vascular smooth muscle. Am J Physiol Heart Circ Physiol. 2015;308(5):H398\u2013406.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5272","key":"66_CR42","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1126\/science.273.5272.245","volume":"273","author":"K Kimura","year":"1996","unstructured":"Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, et al. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science. 1996;273(5272):245\u20138.","journal-title":"Science"},{"issue":"16","key":"66_CR43","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1021\/bi5001728","volume":"53","author":"M Khasnis","year":"2014","unstructured":"Khasnis M, Nakatomi A, Gumpper K, Eto M. Reconstituted human myosin light chain phosphatase reveals distinct roles of two inhibitory phosphorylation sites of the regulatory subunit, MYPT1. Biochemistry. 2014;53(16):2701\u20139.","journal-title":"Biochemistry"},{"issue":"20","key":"66_CR44","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1182\/blood-2013-03-487850","volume":"122","author":"A Aburima","year":"2013","unstructured":"Aburima A, Wraith KS, Raslan Z, Law R, Magwenzi S, Naseem KM. cAMP signaling regulates platelet myosin light chain (MLC) phosphorylation and shape change through targeting the RhoA-Rho kinase-MLC phosphatase signaling pathway. Blood. 2013;122(20):3533\u201345.","journal-title":"Blood"},{"issue":"2","key":"66_CR45","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4067\/S0716-97602002000200016","volume":"35","author":"WT Arthur","year":"2002","unstructured":"Arthur WT, Noren NK, Burridge K. Regulation of Rho family GTPases by cell-cell and cell-matrix adhesion. Biol Res. 2002;35(2):239\u201346.","journal-title":"Biol Res"},{"issue":"2","key":"66_CR46","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.molcel.2004.10.010","volume":"16","author":"JE Hoberg","year":"2004","unstructured":"Hoberg JE, Yeung F, Mayo MW. SMRT derepression by the IkappaB kinase alpha: a prerequisite to NF-kappaB transcription and survival. Mol Cell. 2004;16(2):245\u201355.","journal-title":"Mol Cell"},{"issue":"8","key":"66_CR47","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1038\/jid.2011.89","volume":"131","author":"X Wu","year":"2011","unstructured":"Wu X, Sells RE, Hwang ST. Upregulation of inflammatory cytokines and oncogenic signal pathways preceding tumor formation in a murine model of T-cell lymphoma in skin. J Invest Dermatol. 2011;131(8):1727\u201334.","journal-title":"J Invest Dermatol"},{"issue":"13","key":"66_CR48","doi-asserted-by":"publisher","first-page":"6002","DOI":"10.1073\/pnas.91.13.6002","volume":"91","author":"ME Kadin","year":"1994","unstructured":"Kadin ME, Cavaille-Coll MW, Gertz R, Massague J, Cheifetz S, George D. Loss of receptors for transforming growth factor beta in human T-cell malignancies. Proc Natl Acad Sci USA. 1994;91(13):6002\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"29","key":"66_CR49","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.1038\/onc.2010.172","volume":"29","author":"S Nakahata","year":"2010","unstructured":"Nakahata S, Yamazaki S, Nakauchi H, Morishita K. Downregulation of ZEB1 and overexpression of Smad7 contribute to resistance to TGF-beta1-mediated growth suppression in adult T-cell leukemia\/lymphoma. Oncogene. 2010;29(29):4157\u201369.","journal-title":"Oncogene"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41375-018-0066-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-018-0066-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-018-0066-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T06:41:20Z","timestamp":1693550480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-018-0066-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,22]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["66"],"URL":"https:\/\/doi.org\/10.1038\/s41375-018-0066-4","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,22]]},"assertion":[{"value":"9 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}